CareDx (CDNA) Tops Q3 EPS by 36c, Beats on Revenue; Offers FY25 Revenue Guidance

CareDx (NASDAQ: CDNA) reported Q3 EPS of $0.28, $0.36 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.1 million versus the consensus estimate of $95.32 million.

GUIDANCE:

CareDx sees FY2025 revenue of $372-376 million, versus the consensus of $368.9 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error